Glofitamab
Drug timelines are a Plus or Pro feature.
35 regulatory and trial events tracked for Glofitamab, covering 2024-03-25 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept [Phase 2]